Bicara Therapeutics (BCAX) Shares Issued (2024 - 2026)

Bicara Therapeutics has reported Shares Issued for 3 years, with the latest figure at $161.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $161.8 million; the trailing twelve-month figure through Mar 2026 stood at $164.5 million (up 11115.13% YoY), and the FY2025 full-year result was $2.8 million, up 72.26% from the prior year.
• Shares Issued for Q1 2026 stood at $161.8 million, up from $2.8 million in the prior quarter.
• The five-year high for Shares Issued was $161.8 million in Q1 2026, with the low at -$595000.0 in Q3 2025.
• Historically, Shares Issued has averaged $20.8 million across 3 years, with a median of $366000.0 in 2024.
• The largest YoY upside for Shares Issued was 3488.31% in 2025 against a maximum downside of 1091.67% in 2025.
• Bicara Therapeutics' Shares Issued stood at $77000.0 in 2024, then surged by 3488.31% to $2.8 million in 2025, then jumped by 5754.61% to $161.8 million in 2026.
• The last three Shares Issued figures came in at $161.8 million (Q1 2026), $2.8 million (Q4 2025), and -$595000.0 (Q3 2025), per Business Quant data.